Biodexa Pharmaceuticals PLCNASDAQ:BDRX
- LAST PRICE0.7421
- TODAY'S CHANGE (%)-0.0289 (-3.7484%)
- Bid / Lots0.7500/ 2
- Ask / Lots0.7600/ 1
- Open / Previous Close0.7732 / 0.7710
- Day Range
- 52 Week Range
- Volume272,012
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BDRX |
|---|---|---|
| 09:32 ET | 766 | 0.775001 |
| 09:36 ET | 300 | 0.7702 |
| 09:38 ET | 8795 | 0.7749 |
| 09:39 ET | 21606 | 0.76 |
| 09:41 ET | 2550 | 0.76 |
| 09:43 ET | 300 | 0.76 |
| 09:48 ET | 2000 | 0.76 |
| 09:57 ET | 1200 | 0.7611 |
| 10:01 ET | 300 | 0.769999 |
| 10:10 ET | 786 | 0.77 |
| 10:12 ET | 400 | 0.765 |
| 10:14 ET | 100 | 0.765 |
| 10:17 ET | 11800 | 0.756752 |
| 10:19 ET | 100 | 0.7578 |
| 10:21 ET | 2700 | 0.7515 |
| 10:24 ET | 10337 | 0.75 |
| 10:26 ET | 3800 | 0.75 |
| 10:28 ET | 1500 | 0.7499 |
| 10:30 ET | 4447 | 0.749 |
| 10:32 ET | 28933 | 0.76 |
| 10:33 ET | 5109 | 0.7503 |
| 10:35 ET | 362 | 0.755 |
| 10:37 ET | 388 | 0.765 |
| 10:44 ET | 997 | 0.755 |
| 10:48 ET | 2200 | 0.76 |
| 10:51 ET | 700 | 0.747 |
| 10:55 ET | 2842 | 0.7471 |
| 11:00 ET | 9400 | 0.7471 |
| 11:02 ET | 500 | 0.7483 |
| 11:06 ET | 100 | 0.749 |
| 11:08 ET | 200 | 0.749 |
| 11:09 ET | 150 | 0.749 |
| 11:11 ET | 1040 | 0.759945 |
| 11:13 ET | 1506 | 0.74901 |
| 11:18 ET | 1317 | 0.75475 |
| 11:24 ET | 280 | 0.757 |
| 11:26 ET | 823 | 0.7551 |
| 11:27 ET | 2928 | 0.7472 |
| 11:29 ET | 1000 | 0.747 |
| 11:31 ET | 640 | 0.745 |
| 11:42 ET | 1000 | 0.75 |
| 11:47 ET | 500 | 0.75 |
| 11:51 ET | 1000 | 0.75 |
| 11:54 ET | 538 | 0.7455 |
| 11:58 ET | 500 | 0.74775 |
| 12:00 ET | 668 | 0.7455 |
| 12:02 ET | 436 | 0.7455 |
| 12:07 ET | 863 | 0.7499 |
| 12:12 ET | 868 | 0.7475 |
| 12:21 ET | 2400 | 0.745 |
| 12:25 ET | 500 | 0.7475 |
| 12:30 ET | 632 | 0.75 |
| 12:32 ET | 2500 | 0.746 |
| 12:36 ET | 500 | 0.746 |
| 12:38 ET | 500 | 0.7461 |
| 12:45 ET | 1200 | 0.749 |
| 12:48 ET | 16966 | 0.755 |
| 12:52 ET | 350 | 0.7546 |
| 12:57 ET | 3000 | 0.75 |
| 12:59 ET | 5747 | 0.752 |
| 01:12 ET | 3000 | 0.742 |
| 01:14 ET | 5726 | 0.751089 |
| 01:24 ET | 2675 | 0.7414 |
| 01:32 ET | 1500 | 0.7511 |
| 01:37 ET | 501 | 0.7512 |
| 01:39 ET | 934 | 0.7471 |
| 01:44 ET | 1400 | 0.743 |
| 01:46 ET | 250 | 0.745 |
| 01:53 ET | 2850 | 0.743 |
| 02:00 ET | 270 | 0.751 |
| 02:08 ET | 100 | 0.74855 |
| 02:29 ET | 110 | 0.746 |
| 02:38 ET | 400 | 0.743 |
| 02:54 ET | 400 | 0.744 |
| 03:00 ET | 190 | 0.7511 |
| 03:05 ET | 3056 | 0.7431 |
| 03:07 ET | 132 | 0.743 |
| 03:12 ET | 400 | 0.743 |
| 03:23 ET | 700 | 0.743 |
| 03:25 ET | 1393 | 0.743 |
| 03:27 ET | 200 | 0.7428 |
| 03:38 ET | 100 | 0.7428 |
| 03:41 ET | 100 | 0.7421 |
| 03:43 ET | 300 | 0.7428 |
| 03:45 ET | 350 | 0.7429 |
| 03:48 ET | 606 | 0.7428 |
| 03:50 ET | 1100 | 0.7453 |
| 03:56 ET | 853 | 0.7494 |
| 03:57 ET | 4579 | 0.7401 |
| 03:59 ET | 6400 | 0.7421 |
Jul 23, 2024
Announces Closing of $5.0 Million Registered Direct Offering and Concurrent Private Placement, from 8:30AM ET on Tuesday Jul 23, 2024 by Dow Jones
8:30AM ET on Tuesday Jul 23, 2024 by Dow Jones
Jul 19, 2024
Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement, from 8:30AM ET on Friday Jul 19, 2024 by Dow Jones
8:30AM ET on Friday Jul 19, 2024 by Dow Jones
Jul 16, 2024
Biodexa Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada, from 8:30AM ET on Tuesday Jul 16, 2024 by Dow Jones
8:30AM ET on Tuesday Jul 16, 2024 by Dow Jones
Jul 11, 2024
Jul 2, 2024
Positive Phase 1 Clinical Data of MTX110 in DMG Brain Cancer Demonstrating Increased Survival Presented at ISPNO 2024, from 8:30AM ET on Tuesday Jul 02, 2024 by Dow Jones
8:30AM ET on Tuesday Jul 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biodexa Pharmaceuticals PLC | 11.2M | 0.0x | --- |
Nuo Therapeutics Inc | 15.0M | -4.4x | --- |
Yubo International Biotech Ltd | 16.9M | -11.7x | --- |
Vaccinex Inc | 10.9M | -0.1x | --- |
Curative Biotechnology Inc | 14.4M | -1.6x | --- |
Neurosense Therapeutics Ltd | 14.6M | -1.1x | --- |
Company Information
Biodexa Pharmaceuticals PLC is a United Kingdom-based clinical-stage biopharmaceutical company. The Company is developing a pipeline of products for the treatment of diseases with unmet medical needs. Its technologies include Biodexa Pharmaceuticals Q-Sphera, MidaCore and MidaSolve. The Q-Sphera technology focuses on long-acting injectables using proprietary three-dimensional (3D) printing technology that encapsulates medicines into bioresorbable polymer microspheres with precision characteristics. The MidaCore technology platform uses ultra-small gold nanoparticle (GNP) drug conjugates. The MidaSolve Nano Inclusion technology solubilizes molecules that have minimal solubility biological potential of Hydrogen (pH), extending available routes of administration, including direct-to-tumor delivery. Its pipeline includes MTX110, MTD201, MTD211 (Schizophrenia, MDD), MTX223, and MTD217.
Contact Information
- Headquarters
- 1 Caspian Point, Caspian WayABINGDON, United Kingdom CF10 4DQ
- Phone
- 123-584-1575
- Fax
- ---
Executives
- Non-Executive Chairman of the Board
- Stephen Parker
- Chief Executive Officer, Chief Financial Officer, Executive Director, Secretary
- Stephen Stamp
- Chief Scientific Officer
- Dmitry Zamoryakhin
- Vice President - Head of Clinical Operations
- Vincent Holmes
- Vice President - Technology
- Daniel Palmer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $11.2M |
|---|---|
Revenue (TTM) | $489.6K |
Shares Outstanding | 36.3K |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.47 |
EPS | $-24.21 |
Book Value | $2.02 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 22.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,103.41% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
